Talk:CHE391L/S13/Genome Editing: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
*'''[[User:Benjamin Gilman|Benjamin Gilman]] 12:29, 8 April 2013 (EDT)''': Finish/add a new figure that shows a simple comparison of ZFN, TALEN, and rGEN target sites and structure of Cas9/sgRNA (and isn't under nature copyright) | *'''[[User:Benjamin Gilman|Benjamin Gilman]] 12:29, 8 April 2013 (EDT)''': Finish/add a new figure that shows a simple comparison of ZFN, TALEN, and rGEN target sites and structure of Cas9/sgRNA (and isn't under nature copyright) | ||
*'''[[User:Benjamin Gilman|Benjamin Gilman]] 14:28, 8 April 2013 (EDT)''': Add mention of 2012 Freiburg iGEM team which biobricked TAL domains, Harvard 2012 zinc finger binding domain search | *'''[[User:Benjamin Gilman|Benjamin Gilman]] 14:28, 8 April 2013 (EDT)''': Add mention of 2012 Freiburg iGEM team which biobricked TAL domains, Harvard 2012 zinc finger binding domain search | ||
*'''[[User:Benjamin Gilman|Benjamin Gilman]] 19:29, 8 April 2013 (EDT)''': Use CASCADE nomenclature for type I CRISPR nuclease complex | |||
*'''[[User:Kevin Baldridge|Kevin Baldridge]] 17:01, 8 April 2013 (EDT)''':In the CRISPR/Cas9 section, you refer to crRNAs -- I assume this is cis-repressive, but it might but good to write that out with the abbreviation the first time it's mentioned | *'''[[User:Kevin Baldridge|Kevin Baldridge]] 17:01, 8 April 2013 (EDT)''':In the CRISPR/Cas9 section, you refer to crRNAs -- I assume this is cis-repressive, but it might but good to write that out with the abbreviation the first time it's mentioned | ||
**'''[[User:Benjamin Gilman|Benjamin Gilman]] 19:26, 8 April 2013 (EDT)''': It's a little silly, but crRNA just stands for CRISPR RNA. I'll make a note of it in the text. | **'''[[User:Benjamin Gilman|Benjamin Gilman]] 19:26, 8 April 2013 (EDT)''': It's a little silly, but crRNA just stands for CRISPR RNA. I'll make a note of it in the text. | ||
Revision as of 16:29, 8 April 2013
Benjamin Gilman 12:29, 8 April 2013 (EDT): Currently planned edits:
- Benjamin Gilman 13:23, 8 April 2013 (EDT): Fix typos
- Benjamin Gilman 12:29, 8 April 2013 (EDT): Add a few references, particularly for targeting in different organisms. Move reference tags.
- Benjamin Gilman 12:29, 8 April 2013 (EDT): Finish/add a new figure that shows a simple comparison of ZFN, TALEN, and rGEN target sites and structure of Cas9/sgRNA (and isn't under nature copyright)
- Benjamin Gilman 14:28, 8 April 2013 (EDT): Add mention of 2012 Freiburg iGEM team which biobricked TAL domains, Harvard 2012 zinc finger binding domain search
- Benjamin Gilman 19:29, 8 April 2013 (EDT): Use CASCADE nomenclature for type I CRISPR nuclease complex
- Kevin Baldridge 17:01, 8 April 2013 (EDT):In the CRISPR/Cas9 section, you refer to crRNAs -- I assume this is cis-repressive, but it might but good to write that out with the abbreviation the first time it's mentioned
- Benjamin Gilman 19:26, 8 April 2013 (EDT): It's a little silly, but crRNA just stands for CRISPR RNA. I'll make a note of it in the text.
